APROSTEN

Food supplement composed of an association of active ingredients aimed at assisting prevention of the onset of degenerative pathologies to the prostate.
Catechine
Extracted from deteinated green tea, they are polyphenol flavonoids with strong antioxidant, metabolic action. They provide vasal protection by inhibiting glycoprotein deposit on the pot.
Licopene
Main nutrient present in tomatoes belongs to the class of carotenoids. He has proven to have a remarkable antioxidant activity.
Soy and Isoflavonoids
Plants contained in the normal Mediterranean diet include a wide range of biologically active phytoestrogens. The best studied class is the isoflavones found in soy products. Soy contains in particular 3 types of isoflavones and four forms of chemical compounds.
Selenium
It is an element found in the soil and a micronutrient found in many plants. It has numerous antiproliferative and antioxidant properties.
Vitamin E
It is a nutrient consisting of 2 fractions: gamma and alpha tocopherol. The main source of alpha tocopherol is represented by numerous plants and nuts. The main property of alpha-tocopherol is that of, cellular antioxidant.
Thanks to the presence of high doses of catechins, active fraction of the camellia sinensis (green tea), together with high doses of lycopene, isoflavones of soy, vitamin E, selenium, can be defined the remedy to favor physiological functions and the health of the prostate.

Ingredients

	for 1 tablet
Chetachine	250 mg
Licopene	6 mg
Soy Isoflavones	16 mg
Vitamin E	30 mg
Selenium	40μg

Mode of use
It is recommended to take, regular and constant, 1 tablet daily, except for different prescription, even close to meals for long periods.

Warnings
Do not exceed the recommended daily dose.
Keep out of reach of children under three years of age.
Supplements should not be understood as substitutes for a varied diet.
For pregnant or breastfeeding women and children it is recommended to feel the medical advice.

Format
Pack of 30 tablets coated triple layer "fast-slow".

Cod. 1100.

Bibliography
-Borrelli BK et al, The Cochrane Library 3,2009.
-Clement Y, Prev Med 49:83,2009.
-Colli JL et al, Curr Urol Rep 10:165,2010.
-Fleshner N et al, Cancer 110:1889,2007.
-Gaziano JM et al, JAMA 301:52,2009.
-Goetzl MA et al, Pros Can Pros Dis 10:216,2007.
-Haseen F et al, Pros Can Pros Dis 12:325,2009.
-Jian L, Mol Nutr Food Res 53:217,2009.
-Johnson JJ et al, Phytomedicine 17:3.2010.
-Kavanaugh CJ et al, JNCI 99:1074,2007.
-Lippman SM et al, JAMA 301:39,2009.
-Perabo FGE et al, Prost Can Pros Dis 11:6,2008.
-Sonn GA et al, Pros Can Pros Dis 8:304,2005.
-Steiner C et al, Brit J Nutr 99:ES78,2008.
-Stephenson AJ et al, Urol Clin North Am 37:11,2010.
-Syed DN et al, Cancer Lett 265:167,2008.
-Van Patten CL et al, J Urol 180:2314,2008.